Stay updated on Talque & Teclistamab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Talque & Teclistamab Combo in Myeloma Clinical Trial page.

Latest updates to the Talque & Teclistamab Combo in Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page footer shows a new ClinicalTrials.gov site revision number (updating from v3.5.2 to v3.5.3), reflecting a platform/version update rather than a change to the study record itself.SummaryDifference0.0%

- Check27 days agoChange DetectedThe history shows a new revision v3.5.2 added and v3.5.0 removed, indicating a minor version update to the page.SummaryDifference0.0%

- Check34 days agoChange DetectedNew sections for Adverse Events, Outcome Measures, Baseline Characteristics, and Participant Flow were added in the latest version, along with related document sections.SummaryDifference0.6%

- Check56 days agoChange DetectedAdded a Results Submitted entry and Revision: v3.5.0; Removed No Results Posted and Revision: v3.4.3 from the version history.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision history now includes a new entry v3.4.3 and removes v3.4.2.SummaryDifference0.0%

- Check92 days agoChange DetectedThe page footer shows the site revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Talque & Teclistamab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talque & Teclistamab Combo in Myeloma Clinical Trial page.